biz
play

BIZ Opportunity Day Performance Q32018 Busin iness Ali lignment - PowerPoint PPT Presentation

Dec 02, 2023 •795 likes •1.04k views

BIZ Opportunity Day Performance Q32018 Busin iness Ali lignment Public Company Li Limite ted Date : : N November 27, , 2018 Presentation Agenda Com ompany Ov Overview Business Outlook Financial Performance Q&A

  1. BIZ Opportunity Day Performance Q3’2018 Busin iness Ali lignment Public Company Li Limite ted Date : : N November 27, , 2018

  2. Presentation Agenda ▪ Com ompany Ov Overview ▪ Business Outlook ▪ Financial Performance ▪ Q&A

  3. Company Overview Com ompa pany Pr Profi file Busines siness s Al Alignm gnmen ent (BIZ) IZ) operates the distribution and installation of medical equipments for cancer treatment through radiotherapy by importing the equipments from world’s leading professional in cancer treatment equipment and technology. The company’s operations also include the maintenance service of the mentioned equipments. to being a so solut lution pr provider in cancer treatment which included providing the equipments and other related fixtures, constructing and renovating the venue to be suitable for cancer treatment for both public and private hospitals. Sourcing Maintenance Survey and Overseeing Medical and Installation Design Construction Equipment Service

  4. • Establishment of a Bri rief Company His istory subsidiary to operate specialized hospital for cancer treatment • Expand Business to BIZGenes Y2017 Y2018 Y2000 Y2006 Y2014 Y2016 signed a project increased its centers treating cancer increased its Established registered capital patients with protons registered capital company from 2 MB to 5 MB radiotherapy at King from 1 MB to 2 MB Chulalongkorn Memorial Hospital 1,200 MB • increased its registered capital from 5 MB to 150 MB and then to 200 MB • Trading of BIZ on the Market for Alternative Investment ( mai )

  5. Business Str tructure To operate the distribution and installation of medical equipments for cancer treatment To operate a hospital specializing in cancer treatment

  6. Product and service types based on revenue type Revenue from Sales • which comes from selling and installing the medical equipment Revenue from Services • which comes from providing the maintenance service Revenue from Construction and other Revenues which derived from the project to establish a cancer • patient center with proton particles and other equipment

  7. Presentation Agenda ▪ Company Overview ▪ Business Ou Outlook ▪ Financial Performance ▪ Q&A

  8. Cancer Sta tatistic ics The World Health Organization estimates there to be a consistent increase in the number of new cancer patients each year in Thailand. 250,000 No. of New Cancer Patients 200,000 201,209 Source: World Health Organization 185,735 168,039 150,000 149,758 131,885 123,800 100,000 50,000 0 Y2012 Y2015 Y2020 Y2025 Y2030 Y2035

  9. Demand for Radiotherapy in Thailand The radiotherapy delivery systems currently available in Thailand are not sufficient to provide appropriate treatment for all patients. 131,885 new cancer There are currently 82 103 Current Availability NEEDED DEMAND patients (2015) radiotherapy systems in additional 50% of all cancer patients Thailand.. require radiotherapy (M. radiotherapy Of which, 20 are old Samiei 2013) technology that needs systems ~65,943 new cancer replacement. patients who required needed in radiotherapy (2015) Thailand 400 new cancer patients 62 up-to-date can be admitted to each radiotherapy systems delivery system each year. available. 165 radiotherapy systems required

  10. Srir iracha Cancer Alli lliance Hospital CAH CAH To operate a hospital specializing in cancer treatment between the Company and Group of physicians as a subsidiary of the Company . (Cancer Alliance Co., Ltd.) located at Nongkham sub - district, Sriracha district, Chonburi with 30 rooms for services . The treatment can be classified into 2 main types which are 1) radiotherapy 2) chemotherapy

  11. Pro rogress of f C Construction Sr Sriracha Cancer Alli lliance Hospital

  12. New Business Lin ine BIZ IZ Gen enes “ Distributor of laboratory examinations and services ” Genetic Test for cancer screening is an innovative test to detect genetic mutations resulting in and increased risk of cancer developing. By using the most upfront “Next Generation Sequencing Technology (NGS)”, the personalized results are highly accurate, precise and safe.

  13. BIZ IZGenes: Press Conference (1 (14 Nov 2018 at at Pull ullman Ban angkok Gra rande Suk ukhumvit it)

  14. BIZ IZGenes: Press Conference (1 (14 Nov 2018 at at Pull ullman Ban angkok Gra rande Suk ukhumvit it)

  15. Backlog (a (as of f 30 Sep ep 2018) Prot otons s rad adioth therapy 1,0 1,034 mill illion Bah aht ~1,4 ,400 Expect recognize all revenues within year 2020 mil illion Baht Other pr Othe proje jects ts 36 366 mill illion Bah aht Expect recognize all revenues within Q2’2019

  16. Presentation Agenda ▪ Company Overview ▪ Business Outlook ▪ Fin Financial Per erformance ▪ Q&A

  17. 3Q18 Performance Revenue Re Gross Pr Profi fit Net Net Pr Profi fit Million Baht 282.71 43.02 67.7 172.24 25.69 14.56 3Q2017 3Q2018 3Q2017 3Q2018 3Q2017 3Q2018 282.71 MB 67.70 MB 43.02 MB

  18. 9M18 Performance Revenue Re Gross Pr Profi fit Net Net Pr Profi fit Million Baht 113.13 62.1 451.91 448.93 69.3 35.19 9M2017 9M2018 9M2017 9M2018 9M2017 9M2018 448.93 MB 113.13 MB 62.10 MB

  19. Revenues Str tructure Unit : Million Baht Q3 Q3'1 '18 Q3 Q3'1 '17 YoY Q2 Q2'1 '18 QoQ QoQ Sale les of of Goo oods 226.79 97.54 132.51% 78.03 190.62% Rendering of of Serv ervice 33.05 33.20 -0.43% 63.18 -47.68% +13 137.6 .60% YoY Y Co Constr truction 22.88 41.50 -44.88% 22.06 3.71% 737 37.84 -16 16.4 .44% Tota tal 282.72 172.24 87.20% 163.27 146.65% YoY Y 130.72 616 16.55 -0.66% YoY 446.88 445.99 120.66 44.93 66.24 128.28 96.24 310 10.51 94.4 282 82.71 607.12 73.83 172 72.24 367.61 304.82 286.24 61.70 1.70 236.71 FY15 FY16 FY17 9M17 9M18 Q2'18 Q3'18 Q3'17 Sales of Goods Rendering of Services Construction

  20. Gros Gross s Pro rofit fit 24.75% 23.95% 16.62% 15.77% 14.92% Million Baht 13.90% 15.34% 113.13 43.02 122.67 69.3 85.67 48.98 14.56 FY15 FY16 FY17 9M2017 9M2018 Q3'2017 Q3'2018 Net et Profi rofit 15.17% 13.83% 9.45% Million Baht 7.79% 8.42% 6.60% 6.52% 70.24 43.02 62.1 41.15 35.19 14.56 20.79 FY15 FY16 FY17 9M2017 9M2018 3Q2017 3Q2018 FS S Company

  21. Financial ratio D/E Rat atio io (tim (time) ROE (% (%) 0.69 18.72% 0.62 0.56 0.5 12.54% 9.05% 8.04% 7.05% 0.23 2015 2016 2017 9M17 9M18 2015 2016 2017 9M17 9M18

  22. Presentation Agenda ▪ Company Overview ▪ Business Outlook ▪ Financial Performance ▪ Q& Q&A

  23. Q& Q&A

  24. THANKS! Business Alignment Public Co., Ltd. 92/45 Sathorn Thani Building 2, 16th Floor, North Sathorn Rd., Bangrak, Bangkok 10500 Tel: 02-636-6828-9 Fax: 02-236-3167 Website: www.bizalignment.com e-mail: ir@bizalignment.com

Recommend

More recommend